Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter]

Simmi Wiggins,1,* Noah A Levit2,* 1Sanofi, 410 Thames Valley Park Dr, Reading, RG6 1PT, UK; 2Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA*These authors contributed equally to this workCorrespondence: Simmi Wiggins, Sanofi, 410 Thames Valley Park Dr, Reading, RG6 1...

Full description

Bibliographic Details

Published in:	ImmunoTargets and Therapy
Main Authors:	Wiggins S, Levit NA
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-05-01
Subjects:	dupilumab prurigo nodularis skin infections
Online Access:	https://www.dovepress.com/dupilumab-treatment-is-not-associated-with-increased-risk-of-overall-s-peer-reviewed-fulltext-article-ITT